XTANT MEDICAL HOLDINGS, INC. Debt Instrument, Convertible, Conversion Price
XTANT MEDICAL HOLDINGS, INC. (XTNT) had Debt Instrument, Convertible, Conversion Price of $9.11 per share as of 2018-01-17, per its 10-Q filed 2018-05-08.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2018-05-08
- 2018-01-17: Debt Instrument, Convertible, Conversion Price $9.11.
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2018-01-17 | $9.11 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |